Search

everythinglearnresearchcommunity

for

Search:↓

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

Dutasteride is the most effective hair loss treatment after 24 weeks, but finasteride leads to the most hair growth after 48 weeks.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Imiquimod may be a better non-surgical treatment for cervical pre-cancer, but its effectiveness for vaginal pre-cancer is unclear, and it has some side effects.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Activated PRP injections are effective in treating hair loss and improving hair density.

People with Alopecia Areata are more likely to have certain health issues like ulcerative colitis and type 1 diabetes, but less likely to have others like hypertension and type 2 diabetes.

Hormone treatment before hypospadias surgery can increase penis size and reduce surgery complications.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Finasteride helps improve hair growth in men with hair loss but may increase the risk of erectile dysfunction.

Tailor treatments for vitiligo to patient needs for best results.

The conclusion is that certain traits, including perceived facial aging and BMI, are linked to perceived youthfulness differently in men and women.

The conclusion is that certain traits, including perceived facial aging and BMI, are linked to how youthful people look, with some differences between males and females.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

Physical activity, height, and smoking affect prostate cancer risk.

PRP improves hair thickness for both genders, but only increases hair density in men.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Melatonin improved secondary hair growth in goats but didn't affect primary hair density or litter size.

More research is needed to confirm if Platelet-Rich Plasma (PRP) is effective for treating hair loss.